Correlation of genomic alterations assessed by next-generation sequencing (NGS) of tumor tissue DNA and circulating tumor DNA (ctDNA) in metastatic renal cell carcinoma (mRCC): potential clinical implications

INTRODUCTION: Tumor tissue and circulating tumor DNA (ctDNA) next-generation sequencing (NGS) testing are frequently performed to detect genomic alterations (GAs) to help guide treatment in metastatic renal cell carcinoma (mRCC), especially after progression on standard systemic therapy. Our objecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Hahn, Andrew W., Gill, David M., Maughan, Benjamin, Agarwal, Archana, Arjyal, Lubina, Gupta, Sumati, Streeter, Jessica, Bailey, Erin, Pal, Sumanta K., Agarwal, Neeraj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464894/
https://www.ncbi.nlm.nih.gov/pubmed/28431395
http://dx.doi.org/10.18632/oncotarget.16833

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464894/
https://www.ncbi.nlm.nih.gov/pubmed/28431395
http://dx.doi.org/10.18632/oncotarget.16833

Ejemplares similares